HDL Therapeutics, Inc.
Biotechnology company · Vero Beach, Florida, United States
HDL Therapeutics, Inc. is a biotechnology company headquartered in Vero Beach, Florida, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $1.3 million sold in a notice filed in 2023.
HDL Therapeutics at a glance
What does HDL Therapeutics do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $1.3 million sold (2023).
Frequently asked questions about HDL Therapeutics
Where is HDL Therapeutics headquartered?
HDL Therapeutics, Inc. is headquartered in Vero Beach, Florida, United States.
What does HDL Therapeutics do?
HDL Therapeutics, Inc. is a biotechnology company.
When was HDL Therapeutics founded?
The earliest incorporation on record for HDL Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences